Skip to main content
. Author manuscript; available in PMC: 2016 Oct 16.
Published in final edited form as: Am J Health Econ. 2015 Oct 16;1(4):399–431. doi: 10.1162/AJHE_a_00024

TABLE 6.

Effect of MA managed care penetration on utilization for enrollees with chronic conditions

Total hospital admissions Hospital medical days Hospital surgical days Outpatient ambulatory visits Outpatient surgical visits
Penetration (instrumented)   −0.446
   (0.799)
   −22.39a
    (8.480)
  −6.568b
   (3.290)
       76.48a
      (22.85)
    3.158a
   (0.958)
R2     0.098        0.081     0.024          0.103     0.027
Mean of dep. var. 545 2,240 960 10,865 377
10 pct. pt. pen. incr. effect (%)   −0.818      −9.996   −6.842          7.039     8.377

Data sources: CMS Medicare claims data inpatient, outpatient, and carrier files, Medicare beneficiary enrollment files, and MA Ratebook Files for 1999–2011. Data are limited to beneficiaries with at least one chronic condition (including diabetes, heart disease, or chronic obstructive pulmonary disease).

Notes: Results are for years 1999–2011 and contain 25,974,810 observations. Results for outpatient surgical visits are for years 1999–2009 and contain 23,225,305 observations. MA Penetration is in percentages (ranging from 0 to 100). Results for utilization are per 1,000 enrollees. Regressions include county and year fixed effects; enrollee-level covariates; and county-level demographics, economic conditions, and health-care workforce. Standard errors in parentheses (robust, clustered on county). Bottom row shows the effect implied by the coefficient of a 10 percentage point increase in penetration on the outcome as a percentage of the mean value of the outcome.

a

p < 0.01,

b

p < 0.05,

c

p < 0.10.